Literature DB >> 21676145

The evaluation and treatment of nocturia: a consensus statement.

Jeffrey P Weiss1, Jerry G Blaivas, Donald L Bliwise, Roger R Dmochowski, Catherine E Dubeau, Franklin C Lowe, Steven P Petrou, Philip E V Van Kerrebroeck, Raymond C Rosen, Alan J Wein.   

Abstract

What's known on the subject? and What does the study add? Nocturia is currently defined by the International Continence Society (ICS) as the complaint that an individual has to wake at night one or more times to void. It is, however, an underreported, understudied, and infrequently recognized problem in adults. Many factors may contribute to nocturia which are treatable, yet patients do not seek care or the condition may not be identified by providers. This paper aims to help healthcare providers better serve patients who are experiencing nocturia by summarizing current research, clinical approaches, and treatment options. The results of the conference provide a balanced evaluation of the full treatment armamentarium capable of meeting the needs of patients with the manifold causes of nocturia such as nocturnal polyuria, overactive bladder, or benign prostatic hyperplasia.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 21676145     DOI: 10.1111/j.1464-410X.2011.10175.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  32 in total

1.  Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies.

Authors:  Matthias Oelke; Jeffrey P Weiss; Charalampos Mamoulakis; David Cox; Dustin Ruff; Lars Viktrup
Journal:  World J Urol       Date:  2014-02-07       Impact factor: 4.226

2.  Nocturia: Evaluation and Current Management Strategies.

Authors:  Casey G Kowalik; Joshua A Cohn; Sophia Delpe; W Stuart Reynolds; Melissa R Kaufman; Doug F Milam; Alan J Wein; Roger R Dmochowski
Journal:  Rev Urol       Date:  2018

3.  Prevalence, subtypes, and correlates of nocturia in the symptoms of Lower Urinary Tract Dysfunction Research Network cohort.

Authors:  J Quentin Clemens; Jonathan B Wiseman; Abigail R Smith; Cindy L Amundsen; Claire C Yang; Megan S Bradley; Ziya Kirkali; Nnenaya Q Agochukwu; Anne P Cameron
Journal:  Neurourol Urodyn       Date:  2020-04-06       Impact factor: 2.696

4.  Behavioral treatment of insomnia: also effective for nocturia.

Authors:  Shachi Tyagi; Neil M Resnick; Subashan Perera; Timothy H Monk; Martica H Hall; Daniel J Buysse
Journal:  J Am Geriatr Soc       Date:  2014-01-02       Impact factor: 5.562

5.  Nocturia.

Authors:  Mark S Soloway; Jeffrey P Weiss; Alan J Wein
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

6.  Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH).

Authors:  Richard Berges; Klaus Höfner; Michael Gedamke; Matthias Oelke
Journal:  World J Urol       Date:  2014-08-19       Impact factor: 4.226

7.  The relationship between functional health literacy and obstructive sleep apnea and its related risk factors and comorbidities in a population cohort of men.

Authors:  Joule J Li; Sarah L Appleton; Gary A Wittert; Andrew Vakulin; R Douglas McEvoy; Nick A Antic; Robert J Adams
Journal:  Sleep       Date:  2014-03-01       Impact factor: 5.849

8.  Nocturia: focus on etiology and consequences.

Authors:  Jeffrey P Weiss
Journal:  Rev Urol       Date:  2012

Review 9.  Nocturia: Current Evaluation and Treatment for Urology.

Authors:  Tony Nimeh; Pedro Alvarez; Naem Mufarreh; Lori B Lerner
Journal:  Curr Urol Rep       Date:  2015-09       Impact factor: 3.092

10.  Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.

Authors:  Brian D Gonzalez; Brent J Small; Mallory G Cases; Noelle L Williams; Mayer N Fishman; Paul B Jacobsen; Heather S L Jim
Journal:  Cancer       Date:  2017-10-26       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.